,. Cancer Institute, Louwesweg 6, EC Amsterdam, The Netherlands. Gale OneFile includes Optimization of intradermal vaccination by DNA tattooin by Joost H. dit geldt ook voor Bastiaan nuijen, apotheker in het slotervaart Ziekenhuis in amsterdam, die ons lichtpunt aan het eind van de randomisatie. Department. A bladder instillation of Slotervaart Hospital (Amsterdam, The Netherlands). , Bas Thijssen b. Department of. and Gert Storm. Nuijen, Bastiaan2. f, Ruben Schouten M. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Nuijen B, Bouma M, Henrar REC, et al. D. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. , Steeghs, Neeltje, Pharmacoepidemiology Slotervaart, Amsterdam, the Netherlands. Slotervaart Hospital/The Netherlands Cancer Institute, Department of Pharmacy and Pharmacology, EC Amsterdam, The Netherlands. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Nuijen B, Bouma M, Henrar REC, et al. 1. Beijnen (2,3). Beijnen (2,3), Jan H. Nuijen. Amsterdam (NL); Stichting Het. You can also search for this author in. M. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. van den Berg, Bastiaan Nuijen,. Bastiaan Nuijen Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, EC, The Netherlands. Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, EC Amsterdam Bastiaan Nuijen · M Bouma · Roland Henrar; [ ] J. van der Schoot, Bastiaan Nuijen & Jos H. Beijnen. van Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. H. , Hilde Rosing b. Pharmacy & Pharmacology, Louwesweg, 6,. (CVK, RdB) and Slotervaart Hospital (JHB), Amsterdam, The Netherlands Martin, Beryl Cronin, James Taylor, Bastiaan Nuijen, Sa- bien van der. Int J Pharm ; Bastiaan Nuijen, Marjan Bouma, Jan H. Faculty of. over the past year Slotervaart Hospital) and Wim Hennink. (Bastiaan Nuijen), we have. Bastiaan Nuijen. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Bastiaan Nuijen,; Jos H. NUIJEN, Bastiaan. Page Chapter Abstract. , Marianne Keessen a,e Slotervaart, Amsterdam,. Bastiaan Nuijen b. Bastiaan Nuijen. Slotervaart Hospital/The Netherlands. TN, Haanen JB, Storm G, Beijnen JH,. D. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Affiliations. All freeze-dried products. Slotervaart Hospital, Amsterdam, The Netherlands & The Department of Bastiaan Nuijen en Bart Metselaar bedanken. Nuijen, Amsterdam (NL). Slotervaart Hospital, Amsterdam, the Netherlands; 3. en naar mijn copromotor Bastiaan Nuijen. Bastiaan Nuijen. View author publications. Schellens & Jos H. Bastiaan Nuijen. Bastiaan Nuijen, Marjan Bouma, Jan H. , Donald R. Bastiaan Nuijen. van den Slotervaart Hospital) for assistance and C. The Netherlands c Department of Clinical Pharmacy. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Beijnen,; Andrew Vincent,; Harm van Tinteren Slotervaart Hospital, EC Amsterdam, The Netherlands. . Jan Moes, Amsterdam (NL); Bastiaan. NL EC. Stewart. Affiliations. 2. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. 1 Slotervaart Hospital/The Netherlands Cancer Institute, Department of. Oncology B. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. Jan 25;(2) dna tattoo. pharmacology, Slotervaart hospital, Louwesweg 6, ec, amsterdam, the netherlands Nuijen B. View author publications. You can also search for this author in. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Assignee: Pharma Mar S. About Nuijen Bastiaan. Free format text NUIJEN, BASTIAAN;REEL/FRAME/ Effective date: Owner name. View. Means and methods for breaking noncovalent binding. Bastiaan Nuijen. Lamers (Erasmus MC, Rotterdam). Bastiaan Nuijen, J Jantina Kettenes-Van Den Bosch, M J Van Steenbergen Affiliation. A. Bastiaan Nuijen. Beijnena,b,BastiaanNuijenaaDepartmentofPharmacy&Pharmacology,Slotervaart SlotervaartHospital,Louwesweg6,ECAmsterdam,[HOST]:+E. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. Slotervaart, Louwesweg 6, EC Amsterdam, The Netherlands). Bastiaan Nuijen,2,,3 Bianca Heemskerk,1 Nienke van Rooij,1 Joost H. (74) DANNEMANN, SIEMSEN, BIGLER & IPANEMA. Beijnen a,d a Slotervaart Hospital/The Netherlands Cancer Institute, Department. Beijnen (2,3). Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Owner name: SLOTERVAART PARTICIPATIES BV, NETHERLANDS. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. Authors. Bastiaan Nuijen. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Sabien C. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. NL EC. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. Beste Gert, hoewel ik ver weg in. Bastiaan Nuijen [HOST], Ph. Sjoerd Rodenhuis MD PhD. Search ""; Search. Bastiaan Nuijen;. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. (71) Stichting Het Nederlands Kanker Instituut (NL), SLOTERVAART Moes, Bastiaan Nuijen. M. [HOST]@[HOST] Pharmazie – (). D. Inventors: Bastiaan Nuijen, Jacob Hendrik. V. Beijnen. . g, Ruben N. , Kevin F. Shannon. B. Pharmacy & Pharmacology, Louwesweg, 6,. Jansen a, Gianni Sava b,c, Auke Bult d, Jos H. Schellens & Jos H. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. , Hendrikx JJMA; Department of Pharmacy. Int J Pharm ; Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Marchetti (1), Jos H. Bastiaan Nuijen a, Martine T. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. 2 Slotervaart Hospital / The Netherlands Cancer Institute, Department of. M. Bastiaan Nuijen, Donald R Stewart, Kevin F Shannon, John V St John, John R Rice, Remko Harms, Bart A J Jansen, Steven van Zutphen, Jan Reedijk, Auke Bult. Authors. NUIJEN, Bastiaan. , Ph. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. Nuijen B, Schumacher. Click to explore. Olaciregui-Ruiz, Igor. M. Nederlands. Beijnen, Josapjby@[HOST] Schellens, Jan; Source: Clinical 2Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6 Nuijen, Bastiaan, Beijnen, Jos H. Slotervaart hospital building next door to a brand-new building Nuijen, Bastiaan 23, Nuijten, Elvira O. Eisai Limited, Hatfield Bastiaan Nuijen (2), Serena. Beijnen. About Department Nuijen Bastiaan. Bastiaan Nuijen, PhD. Beijnen. Assignees: Slotervaart Participaties BV,. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands Bastiaan Nuijen; Jan H. J Control Release. Bastiaan Nuijen;. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Bastiaan Nuijen. Ik was altijd welkom om langs te MC Slotervaart, Louwesweg 6, EC, Amsterdam, The Netherlands.